IP Library › Granted Patent US 12,194,201
Granted Patent B2
US 12,194,201 · App. 16/984,042 · Granted Jan 14, 2025

Silica nanoparticle doped conductive polymer

Inventors: Xinyan Cui (Wexford, PA); Kevin M. Woeppel (Pittsburgh, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
A61L31/128A61B5/14532A61B5/14865A61B5/25A61B5/291A61B5/296A61L31/16A61N1/0502A61N1/0534A61N1/0541A61N1/0551A61N1/36007A61N1/36038A61N1/362A61N1/3962A61B5/262A61B5/263A61B5/283A61B2562/0209A61B2562/125A61B2562/14A61L2420/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,194,201
App. No.
16/984,042
Granted
Jan 14, 2025
Kind
B2
Abstract

Disclosed herein are embodiments of a conductive polymer doped with silica nanoparticles. In several embodiments, a coated electrode comprising a coating of the conductive polymer on a conductive surface of the electrode is provided. In some embodiments, the silica nanoparticles of the conductive polymer are mesoporous and are loaded with a pharmaceutical agent. Methods of using the conductive polymer doped with silica nanoparticles are also provided, including methods of recording or stimulating a bioelectric signal and methods of administering a pharmaceutical agent to a subject.

Claims (39)

1. A coated electrode comprising a coating of a conductive polymer doped with negatively charged silica nanoparticles on a conductive surface of the electrode.

2. The coated electrode of claim 1 , wherein the conductive polymer is poly 3,4 ethylene dioxythiophene (PEDOT).

3. The coated electrode of claim 1 , wherein the negatively charged silica nanoparticles are sulfonated silica nanoparticles.

4. The coated electrode of claim 1 , wherein the negatively charged silica nanoparticles are from about 10 to about 500 nm in diameter.

5. The coated electrode of claim 1 , wherein the coating is formed by electropolymerization of a mixture of monomers of the conductive polymer and the negatively charged silica nanoparticles onto a conductive surface of the electrode.

6. The coated electrode of claim 5 , wherein the coating is formed by electropolymerization of a mixture of 3,4 ethylene dioxythiophene (EDOT) monomers and the negatively charged silica nanoparticles onto a conductive surface of the electrode.

7. The coated electrode of claim 1 , wherein the coating on the electrode is from 25 mC cm −2 to 2 C cm −2 as measured during electrodeposition.

8. The coated electrode of claim 1 , wherein the electrode is a gold, platinum, iridium, glassy carbon, steel, tungsten, magnesium, or carbon fiber electrode.

9. The coated electrode of claim 1 , wherein the negatively charged silica nanoparticles are mesoporous.

10. The coated electrode of claim 9 , wherein the mesoporous negatively charged silica nanoparticles comprise pores with an average diameter of from about 1 nm to about 20 nm.

11. The coated electrode of claim 10 , wherein the mesoporous negatively charged silica nanoparticles are formed by a process comprising incubating silica precursors and a surfactant under conditions sufficient to form the mesoporous negatively charged silica nanoparticles.

12. The coated electrode of claim 11 , wherein the surfactant is hexadecyl trimethylammonium bromide (CTAB), hexadecyl trimethylammonium chloride (CTACL), Triton-X, or a poly(ethylene-oxide) derivative.

13. A coated electrode comprising a coating of a conductive polymer doped with negatively charged silica nanoparticles on a conductive surface of the electrode, wherein the negatively charged silica nanoparticles are mesoporous and loaded with a pharmaceutical agent.

14. The coated electrode of claim 13 , wherein the pharmaceutical agent is a small molecule drug.

15. The coated electrode of claim 13 , wherein the pharmaceutical agent is an anti-oxidant, an anti-inflammatory agent, an anti-convulsant agent, an anti-bacterial agent, or an anti-cancer agent.

16. The coated electrode of claim 13 , wherein the pharmaceutical agent is any one of: melatonin, dexamethasone, minocycline, glutamate, GABA, muscimol, bicuculline, AP-5 (amino-5-phosphonovaleric acid), 6,7-dinitroquinoxaline-2,3-dione (DNQX), 6-cyano-7-nitroquinoxaline-2,3-dione, doxorubicin.

17. The coated electrode of claim 1 , wherein impedance and charge storage capacity of the coated electrode remains stable following sonication for 60 minutes.

18. A medical implant comprising the coated electrode of claim 1 .

19. The medical implant of claim 18 , wherein the medical implant is a cardiac pacemaker, a cardiac defibrillator, a deep brain stimulator, a cochlear implant, a peripheral nerve stimulator, a spinal cord stimulator, a neural electrode, an enteric nervous system stimulator, a skin surface electrode (such as ECG, EMG and EEG electrode), an intramuscular electrode, or an implantable glucose sensor.

20. A method of making the coated electrode of claim 1 , comprising:

incubating a mixture of monomers of a conductive polymer and negatively charged silica nanoparticles with a conductive surface of an electrode; and

applying a potential sufficient to oxidize and polymerize the monomers on the conductive surface of the electrode to form a coating of the conductive polymer doped with the negatively charged silica nanoparticles at the conductive surface of the electrode;

thereby forming the coated electrode comprising a coating of a conductive polymer doped with negatively charged silica nanoparticles.

21. The method of claim 20 , wherein the monomers of the conductive polymer are 3,4 ethylene dioxythiophene (EDOT) monomers and the method forms the coated electrode comprising a coating of poly-3,4 ethylene dioxythiophene (PEDOT) doped with negatively charged silica nanoparticles.

22. The method of claim 20 , the method further comprising making the negatively charged silica nanoparticles, comprising:

incubating silica precursors under conditions sufficient to form silica nanoparticles, wherein the silica precursors comprise one or more thiol functional groups, thereby forming thiol modified silica nanoparticles; and

oxidizing the thiol functional groups of the thiol modified silica nanoparticles to form sulfonated silica nanoparticles, thereby forming the negatively charged silica nanoparticles.

23. The method of claim 22 , wherein the negatively charged silica nanoparticles are mesoporous, wherein incubating the silica precursors under the conditions sufficient to form silica nanoparticles comprises incubating the silica precursors with a sufficient amount of a surfactant to form mesoporous silica nanoparticles.

24. The method of claim 20 , wherein the surfactant is hexadecyl trimethylammonium bromide (CTAB).

25. The method of claim 23 , further comprising loading a small-molecule drug on the negatively charged mesoporous silica nanoparticles, comprising incubating the negatively charged mesoporous silica nanoparticles with the small molecules drug in a solution, and sonicating the solution to load the small molecules drug on to the negatively charged mesoporous silica nanoparticles.

26. A method of administering a pharmaceutical agent to a subject, comprising

implanting a medical implant comprising the coated electrode of claim 13 in the subject, and

applying an electrical potential across the electrode to release the pharmaceutical agent from the mesoporous negatively charged silica nanoparticles in the coating to the subject.

27. The method of claim 26 , wherein the electrical potential comprises a cyclic voltametric, sinusoidal, cosine wave, or square wave electrical stimulus.

28. A method of stimulating or recording an electrical signal in a subject, comprising:

implanting a medical implant comprising the coated electrode of claim 1 in the subject, and

stimulating or recording the electrical signal in the subject from the electrode in the implant.

29. A conductive polymer doped with negatively charged silica nanoparticles.

30. The conductive polymer of claim 29 , wherein the conductive polymer is poly 3,4 ethylene dioxythiophene (PEDOT).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2020
From: CUI, XINYAN; WOEPPEL, KEVIN M.
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 054154/0926 →
Continuity (2)
Provisional Application 62884047 · Aug 7, 2019
Related Publication 20210038773A1 · Feb 11, 2021
References Cited (49)
US 20080097280A1 · Martin · 2008 [cited by examiner]
US 20170326381A1 · Kozai · 2017 [cited by examiner]
US 20180333571A1 · Pepin · 2018 [cited by examiner]
US 20200178864A1 · Cui et al. · 2020 [cited by applicant]
US 20210260534A1 · Newbloom · 2021 [cited by examiner]
AU 2018308332A1 · 2020 [cited by examiner]
KR 20050055202A · 2005 [cited by examiner]
WO WO2005082277A1 · 2005 [cited by examiner]
WO WO2007028003A2 · 2007 [cited by examiner]
WO WO2018009924A1 · 2018 [cited by examiner]
Seth J. Wilks1 Sarah M. Richardson-Burns2,3 Jeffrey L. Hendricks3,4 David C. Martin2,3,4 Kevin J. Otto1,5, Jun. 9, 2009, Front. Neuroeng, vol. 2, “Poly(3,4-ethylenedioxythiophene) as a micro-neural interface material fo… [cited by examiner]
Abidian et al., “Conducting-Polymer Nanotubes for Controlled Drug Release,” [cited by applicant]
Bertrand et al., “Double-Blind Study of the Safety of Clopidogrel with and without a Loading Dose in Combination with Aspirin Compared with Ticlopidine in Combination with Aspirin after Coronary Stenting: The Clopidogre… [cited by applicant]
Catt et al., “Self-Powered Therapeutic Release from Conducting Polymer/Graphene Oxide Films on Magnesium,” [cited by applicant]
Chen et al., “Recent Advances in Electrochemical Sensing for Hydrogen Peroxide: A Review,” [cited by applicant]
Cogan et al., “In Vitro Comparison of the Charge-Injection Limits of Activated Iridium Oxide (AIROF) and Platinum-Iridium Mircoelectrodes,” [cited by applicant]
Collinger et al., “7 Degree-of-Freedom Neuroprosthetic Control by an Individual with Tetraplegia,” [cited by applicant]
Du et al., “Electrically Controlled Neurochemical Release from Dual-Layer Conducting Polymer Films for Precise Modulation of Neural Network Activity in Rat Barrel Cortex,” [cited by applicant]
Flesher et al., “Intracortical Microstimulation of Human Somatosensory Cortex,” [cited by applicant]
Golabchi et al., “Melatonin Improves Quality and Longevity of Chronic Neural Recording,” [cited by applicant]
Gomez and Schmidt, “Nerve Growth Factor-Immobilized Polypyrrole: Bioactive Electrically Conducting Polymer for Enhanced Neurite Extension,” [cited by applicant]
Guimard et al., “Conducting Polymers in Biomedical Engineering,” [cited by applicant]
Gulcin et al., “On the In Vitro Antioxidative Properties of Melatonin,” [cited by applicant]
Gupta et al., “Silica Functionalized Sulfonic Acid Catalyzed One-Pot Synthesis of 4,5,8a-triarylhex-ahydropyrimido[4,5-d]pyrimidine-2,7(1H,3 H)-diones under Liquid Phase Catalysis,” [cited by applicant]
Harish et al., “Barrier Films to Control Loss of 9,10-anthraquinone-2-sulphonate Dopant from PEDOT Films during Electrochemical Transitions,” [cited by applicant]
He and Shi, Mesoporous Silica Nanoparticle Based Nano Drug Delivery Systems: Synthesis, Controlled Drug Release and Delivery, Pharmacokinetics and Biocompatibility, [cited by applicant]
Hernandez et al., “Template Fabrication of Protein-Functionalized Gold- Polypyrrole-Gold Segmented Nanowires,” [cited by applicant]
King et al., “Structural, Chemical and Electrochemical Characterization of poly(3,4-ethylenedioxythiophene) (PEDOT) Prepared with Various Counter-Ions and Heat Treatments,” [cited by applicant]
Kozai et al., “Chronic In Vivo Evaluation of PEDOT/CNT for Stable Neural Recordings,” [cited by applicant]
Kozai et al., “Ultrasmall Implantable Composite Microelectrodes with Bioactive Surfaces for Chronic Neural Interfaces,” [cited by applicant]
Kum et al., “Biomolecules-Carbon Nanotubes Doped Conducting Polymer Nanocomposites and Their Sensor Application,” [cited by applicant]
Lai et al., “A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug Molecules,” [cited by applicant]
Lee et al., “Simple Synthesis of Functionalized Superparamagnetic Magnetite/Silica Core/Shell Nanoparticles and their Application as Magnetically Separable High-Performance Biocatalysts,” [cited by applicant]
Leon et al., “A Clinical Trial Comparing Three Antithrombotic-Drug Regimens After Coronary-Artery Stenting. Stent Anticoagulation Restenosis Study Investigators,” [cited by applicant]
Ludwig et al., “Poly(3,4-ethylenedioxythiophene) (PEDOT) Polymer Coatings Facilitate Smaller Neural Recording Electrodes,” [cited by applicant]
Luo and Cui, “Electrochemically Controlled Release Based on Nanoporous Conducting Polymers,” [cited by applicant]
Luo et al., “Highly Stable Carbon Nanotube Doped poly(3,4-ethylenedioxythiophene) for Chronic Neural Stimulation,” [cited by applicant]
Pickup et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer,” [cited by applicant]
Proctor et al., “Electrophoretic Drug Delivery for Seizure Control,” [cited by applicant]
Simon et al., “Organic Electronics for Precise Delivery of Neurotransmitters to Modulate Mammalian Sensory Function,” [cited by applicant]
Stauffer and Cui, “Polyprrole Doped with 2 Peptide Sequences from Laminin,” [cited by applicant]
Thompson et al., “Effect of the Dopant Anion in Polypyrrole on Nerve Growth and Release of a Neurotrophic Protein,” [cited by applicant]
Venkatraman et al., “In Vitro and in Vivo Evaluation of PEDOT Microelectrodes for Neural Stimulation and Recording,” [cited by applicant]
Vlamidis et al., “Electrodeposition of PEDOT Perchlorate as an Alternative Route to PEDOT:PSS for the Development of Bulk Heterojunction Solar Cells,” [cited by applicant]
Wadhwa et al., “Electrochemically Controlled Release of Dexamethasone from Conducting Polymer Polypyrrole Coated Electrode,” [cited by applicant]
Weaver et al., “Electrically Controlled Drug Delivery from Graphene Oxide Nanocomposite Films,” [cited by applicant]
Woeppel et al., “Enhancing Surface Immobilization of Bioactive Molecules via a Silica Nanoparticle Based Coating,” [cited by applicant]
Woeppel et al., “Recent Advances in Neural Electrode-Tissue Interfaces,” [cited by applicant]
Zheng et al., “Soft Conducting Elastomer for Peripheral Nerve Interface,” [cited by applicant]